Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report
International Journal of Dermatology · 12.08.2026
DOI: 10.1111/ijd.70632 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 12.08.2026. Verfasst von Selcen Hoşgören-Tekin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye.
ORCID-Profile: Selcen Hoşgören-Tekin, Ahmet Atas, Dilek Seçkin, Ayşe Deniz Yücelten
Zitieren
APA
Hoşgören-Tekin, S., Atas, A., Seçkin, D., & Yücelten, A. D. (2026). Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. https://doi.org/10.1111/ijd.70632
Vancouver
Hoşgören-Tekin S, Atas A, Seçkin D, Yücelten AD. Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. 2026. doi:10.1111/ijd.70632
BibTeX
@article{HogrenTekin2026,
author = {Hoşgören-Tekin, Selcen and Atas, Ahmet and Seçkin, Dilek and Yücelten, Ayşe Deniz},
title = {Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70632}
}
EUVIMED